Browser-side verification
Verify Sucralfate
คุณไม่ต้องเชื่อ source.cuvetsmo.com — โค้ดด้านล่างทำงานในเครื่องของคุณ คำนวณ SHA-256 และ verify Ed25519 signature เทียบกับ public key ที่อาจารย์เซ็นต์รับเก็บไว้.
Signatures
0
Version
1
Status
pending
⏳ ยังไม่มี signature
Entry นี้ยังไม่ได้ลงนามโดย key ใดเลย — Phase 0 mirror snapshot ที่รอ Thai translation + faculty signoff. ดูสถานะการ review ที่ หน้า detail
Show the raw inputs (paranoid mode)
Drug JSON
This is exactly what your browser canonicalizes + SHA-256-hashes
{
"slug": "sucralfate",
"nameEn": "Sucralfate",
"nameTh": "ซูคราลเฟต",
"class": "GI cytoprotective — sucrose-aluminium complex",
"mechanism": "พอลิเมอร์ sucrose octasulfate ที่จับกับเยื่อบุที่เป็นแผลในภาวะกรด เกิดชั้นเหนียวเคลือบป้องกัน (cytoprotective) ไม่ลดการหลั่งกรดโดยตรง; ออกฤทธิ์เฉพาะที่",
"brandNamesTh": [
"Carafate",
"Antepsin"
],
"indications": [
{
"text": "เคลือบป้องกันแผลในทางเดินอาหารและหลอดอาหารอักเสบ (esophagitis) โดยเฉพาะแผลที่เป็นแล้ว; ใช้เสริม PPI (แต่ต้องแยกเวลา)",
"cites": [
"acvim-gi-protectant"
]
}
],
"contraindications": [
{
"text": "แยกเวลาจาก PPI/H2 blocker และยาอื่นอย่างน้อย 2 ชั่วโมง (ลดการดูดซึมยาอื่น และต้องการกรดเพื่อกระตุ้น); ระวังในสัตว์ไตบกพร่อง (สะสม aluminium)",
"cites": [
"acvim-gi-protectant"
]
}
],
"sideEffects": [
{
"text": "ท้องผูก; ลดการดูดซึมยาอื่นที่ให้พร้อมกัน; ไม่ค่อยมีผลทั่วร่างกายเพราะดูดซึมน้อย",
"cites": [
"acvim-gi-protectant"
]
}
],
"dosages": [
{
"species": "canine",
"indication": "GI ulcer / esophagitis (mucosal protection)",
"route": "PO",
"dose": "สุนัขใหญ่ 0.5–1 g, สุนัขเล็ก 0.25–0.5 g PO ทุก 6–8 ชั่วโมง",
"notes": "⚠️ ตรวจสอบขนาดในตำราเฉพาะทาง (Plumb's) ก่อนใช้; ให้ห่างจากยาอื่นอย่างน้อย 2 ชั่วโมง",
"cites": [
"acvim-gi-protectant",
"merck-antiulcer"
]
},
{
"species": "feline",
"indication": "GI ulcer / esophagitis",
"route": "PO",
"dose": "0.25–0.5 g PO ทุก 8–12 ชั่วโมง",
"notes": "ให้ห่างจากยาอื่นอย่างน้อย 2 ชั่วโมง",
"cites": [
"acvim-gi-protectant"
]
}
],
"citations": [
{
"id": "acvim-gi-protectant",
"type": "guideline",
"title": "ACVIM Consensus Statement: Rational administration of gastrointestinal protectants to dogs and cats",
"authors": "Marks SL, et al.",
"year": 2018,
"url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6271318/",
"note": "Peer-reviewed ACVIM consensus (J Vet Intern Med) — PPI/H2/sucralfate evidence + dosing. Authoritative.",
"cid": null
},
{
"id": "merck-antiulcer",
"type": "textbook",
"title": "Antiulcerative Drugs — MSD/Merck Veterinary Manual",
"year": 2025,
"url": "https://www.merckvetmanual.com/multimedia/table/antiulcerative-drugs",
"note": "Merck antiulcerative dosing table. Copyrighted, cited not mirrored.",
"cid": null
},
{
"id": "dailymed-sucralfate",
"type": "regulatory-database",
"title": "Sucralfate — NLM DailyMed (FDA Structured Product Labeling)",
"year": 2025,
"url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=sucralfate",
"note": "Cross-checked source: FDA-approved labeling. Search by name returns relevant product labelings.",
"cid": "79aead5e3e15c700f39b7e38e86099e8c3136b2b82125ea87794d84eb7c17af4"
},
{
"id": "atc-A02BX02",
"type": "guideline",
"title": "ATC A02BX02 — Sucralfate",
"year": 2025,
"url": "https://www.whocc.no/atc_ddd_index/?code=A02BX02&showdescription=no",
"note": "Cross-checked source: WHO Collaborating Centre ATC/DDD index. Authoritative drug classification.",
"cid": "f1d57d6177c51090fa520272e7b1abc3a9086d6e019e8aad71b36bf2bbf3f737"
},
{
"id": "pubchem-sucralfate",
"type": "monograph",
"title": "Sucralfate — PubChem search",
"year": 2025,
"url": "https://pubchem.ncbi.nlm.nih.gov/#query=Sucralfate",
"note": "Cross-checked source: chemical structure, identifiers, pharmacology summary. Faculty review fills exact CID.",
"cid": "ee50f7e09236f400a2a4a18f7e334434fd741cc1d9692b96d21bd0a6632e720b"
}
],
"mirroredFrom": [
{
"id": "dailymed",
"name": "NLM DailyMed",
"url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=sucralfate",
"asOfDate": "2026-05-27",
"license": "U.S. Government work — public domain. Attribution recommended."
},
{
"id": "atc",
"name": "WHO ATC Classification",
"url": "https://www.whocc.no/atc_ddd_index/?code=A02BX02&showdescription=no",
"asOfDate": "2026-05-27",
"license": "WHO publication, free for use with attribution"
},
{
"id": "pubchem",
"name": "PubChem (NIH/NLM)",
"url": "https://pubchem.ncbi.nlm.nih.gov/#query=Sucralfate",
"asOfDate": "2026-05-27",
"license": "NIH/NLM public domain"
}
],
"mirrorCIDs": [
{
"sourceId": "dailymed",
"cid": "79aead5e3e15c700f39b7e38e86099e8c3136b2b82125ea87794d84eb7c17af4",
"capturedAt": "2026-05-27",
"status": "stub"
},
{
"sourceId": "atc",
"cid": "f1d57d6177c51090fa520272e7b1abc3a9086d6e019e8aad71b36bf2bbf3f737",
"capturedAt": "2026-05-27",
"status": "stub"
},
{
"sourceId": "pubchem",
"cid": "ee50f7e09236f400a2a4a18f7e334434fd741cc1d9692b96d21bd0a6632e720b",
"capturedAt": "2026-05-27",
"status": "stub"
}
],
"codes": {
"atc": {
"code": "A02BX02",
"name": "Sucralfate",
"level": 5
},
"rxnorm": {
"cui": "10156",
"name": "Sucralfate"
}
},
"drafting": {
"aiAssisted": false,
"aiModel": null,
"aiPromptHash": null,
"humanReviewer": "palmzamak2547",
"humanReviewedAt": "2026-05-27",
"humanEditsRatio": null
},
"signatures": [],
"reviewedBy": null,
"lastUpdated": "2026-05-27",
"version": 1,
"changelog": [
{
"version": 0,
"date": "2026-05-27",
"summary": "Seed entry — cross-checked from 3 authoritative sources (NLM DailyMed, WHO ATC Classification, PubChem (NIH/NLM)). ATC A02BX02 + RxNorm 10156. Thai translation + faculty review pending."
},
{
"version": 1,
"date": "2026-05-27",
"summary": "Clinical content compiled from cited sources — sucralfate mucosal-protectant dosing + 2-hour separation rule verified against ACVIM consensus + Merck antiulcerative table; per-weight gram dose flagged for Plumb's faculty confirmation. Every statement cited. Reviewed by palmzamak2547. Pending faculty canonical signature."
}
]
}Public keys used
[]